Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Passes Above Two Hundred Day Moving Average - Here's Why

Key Points

• Sabra Healthcare REIT passed above its 200-day moving average
• Analysts have raised price targets recently and MarketBeat shows a consensus rating of Moderate Buy with a consensus price target of $22.00.
• Fundamentals are mixed: Sabra missed quarterly EPS ($0.11 vs. $0.37 expected) despite 16.2% YoY revenue growth, and it pays a $0.30 quarterly dividend (annualized yield ~5.9%) but with a high payout ratio (187.5%).

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $19.18 and traded as high as $20.57. Sabra Healthcare REIT shares last traded at $20.49, with a volume of 1,394,383 shares trading hands.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Citizens Jmp increased their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a "market outperform" rating in a research note on Wednesday, February 18th. Scotiabank increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "sector perform" rating in a research note on Monday, March 2nd. Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an "overweight" rating in a research note on Thursday, March 26th. UBS Group increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Thursday, February 19th. Finally, Truist Financial increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a "hold" rating in a research note on Friday, March 13th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and a consensus price target of $22.00.

Sabra Healthcare REIT Stock Performance

The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The company has a market capitalization of $5.17 billion, a price-to-earnings ratio of 32.02, a PEG ratio of 1.62 and a beta of 0.67. The stock has a 50 day simple moving average of $20.11 and a two-hundred day simple moving average of $19.18.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. The firm's quarterly revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 187.50%.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Cornerstone Wealth Management LLC grew its holdings in shares of Sabra Healthcare REIT by 256.6% during the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust's stock worth $742,000 after purchasing an additional 28,625 shares during the last quarter. AlphaQuest LLC grew its holdings in shares of Sabra Healthcare REIT by 309.2% during the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust's stock worth $2,700,000 after purchasing an additional 109,444 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its holdings in shares of Sabra Healthcare REIT by 51.2% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust's stock worth $10,770,000 after purchasing an additional 195,600 shares during the last quarter. Allianz Asset Management GmbH grew its holdings in shares of Sabra Healthcare REIT by 9.9% during the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust's stock worth $16,832,000 after purchasing an additional 81,293 shares during the last quarter. Finally, Tred Avon Family Wealth LLC purchased a new position in shares of Sabra Healthcare REIT during the third quarter worth about $979,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.